Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06631053 · ClinicalTrials.gov registry record · NA
FIT Exercise in 30d of ULLS-induced Muscle Disuse
A NA study of Muscle Weakness and Muscle Atrophy, sponsored by Lance Bollinger.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06631053: Recruiting NA study of Muscle Weakness and Muscle Atrophy, sponsored by Lance Bollinger.
NCT06631053 is a NA study of Muscle Weakness and Muscle Atrophy that is actively recruiting participants, run by Lance Bollinger. The registered enrollment target is 16 participants, below the 74-participant average among 25 other Muscle Weakness trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06631053, a NA study of Muscle Weakness and Muscle Atrophy, is actively recruiting participants, sponsored by Lance Bollinger.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine how flywheel-based inertial training (FIT) implemented according to principles of velocity-based training (VBT) and High-Intensity Interval Training (HIIT) affects disuse-induced physical de-conditioning including loss of voluntary muscle strength, aerobic capacity, and balance regulation.
Primary Outcome
Voluntary activation of the quadriceps will be assessed with electrical stimulation of the femoral nerve before, during, and after a maximal voluntary isometric contraction (MVIC) using the interpolated twitch technique.
Conditions Studied
Interventions
- OTHER No Exercise
- OTHER velocity-based FIT (VBFIT)
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-10-23 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT06631053 shows while recruiting
NCT06631053 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 74-participant average among 25 other Muscle Weakness trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Muscle Weakness appearing as the primary indexed condition, and to 2 interventions - of which No Exercise is the first listed.
NCT06631053 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT06631053 about?
NCT06631053 is a clinical study titled "FIT Exercise in 30d of ULLS-induced Muscle Disuse". This study aims to determine how flywheel-based inertial training (FIT) implemented according to principles of velocity-based training (VBT) and High-Intensity Interval Training (HIIT) affects disuse-induced physical de-conditioning including loss of voluntary muscle strength, aerobic capacity, and ...
What is the current status of trial NCT06631053?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2024-10-23. Estimated completion is 2026-09-01.
What conditions does trial NCT06631053 study?
This clinical trial studies the following conditions: Muscle Weakness, Muscle Atrophy.
What interventions are being tested in trial NCT06631053?
The interventions under investigation include: No Exercise (OTHER), velocity-based FIT (VBFIT) (OTHER).
Who is sponsoring clinical trial NCT06631053?
This trial is sponsored by Lance Bollinger, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06631053 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Weakness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06631053's enrollment target sits among peer trials
16 23rd of 25 higher than 2 of 25 other Muscle Weakness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Muscle Weakness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
RECRUITING · NA
-
Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
RECRUITING · NA
-
Assessing The Effects of Exercise, Protein, and Electric Stimulation On Intensive Care Unit Patients Outcomes
ACTIVE NOT RECRUITING · NA
-
Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome
ACTIVE NOT RECRUITING · NA
-
HIFEM and Radiofrequency for Muscular System Function Improvement
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI